20 results on '"Chemical inhibitors"'
Search Results
2. Neurocrine reports encouraging results from Phase II endometriosis pain trial.
3. Cytokinetics and GSK to terminate collaboration and licensing agreement.
4. Curis's collaborator Genentech grants ex-US rights of cancer drug to Roche.
5. Kalypsys starts Phase IIa trial of topical painkiller.
6. VGX Pharmaceuticals files IND for antiinflammatory drug.
7. Telik's proteasome program meets preclinical development milestone.
8. Merck reports positive results from bone metastases study.
9. SuperGen's leukemia drug found to induce tumor regression in xenograft models.
10. Pharming's angioedema drug found to be effective in open label studies.
11. Chocolate: healthy bars reveal their dark side.
12. CoMentis's drug found safe and welltolerated in Alzheimer's therapy.
13. ExonHit receives approval for Phase II trial of Alzheimer's.
14. Gilead: moving HIV hope forward: Gilead has announced plans to move its HIV drug GS 9137 into phase II clinical testing..
15. The Vioxx controversy: COX-II players have tough decisions ahead.
16. Celgene: Revlimid promises much in multiple myeloma.
17. COX-2s: regulatory action on the horizon?
18. Bayer and Onyx initiate pivotal phase III clinical trial in kidney cancer.
19. Vion initiates phase II trial of Triapine and gemcitabine in lung cancer.
20. Novartis' Femara demonstrates early survival advantage over tamoxifen in advanced breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.